ME KATZ, PE SCHWARTZ, DS KAPP, S … - Annals of Internal …, 1981 - Am Coll Physicians Epithelial ovarian cancer is usually diagnosed late in its biologic course (70% of cases are diagnosed
as stage III or IV). Recent advances in chemotherapy and radiation therapy offer the possibility
of long-term disease-free survival and the potential for cure. The selection of treatment for ... Cited by 69 - Related articles - All 2 versions
RC Young, BA Chabner, SP Hubbard, RI … - Obstetrical & …, 1979 - journals.lww.com 414 Obstetrical and Gynecological Survey matched cases, supposedly without high risk for estrogen
administration, the endo- metrial carcinoma risk for estrogen users increases to 6. The importance
of this study is that the risk of cancer is greater among those using a higher dosage of ... Cited by 216 - Related articles - All 6 versions
J Carmo-Pereira, FO Costa, E Henriques, JA … - CA A Cancer Journal … - interscience.wiley.com Fifty-seven evaluable patients with advanced ovarian carcinoma were randomized to receive
either a combination of hexamethylmelamine, cyclophosphamide, methotrexate and 5-fluorouracil
(Hexa-CAF) or high-dose cyclophosphamide alone given intravenously intermittently. ... Cited by 29 - Related articles - All 2 versions
SE Vogl, M Berenzweig, BH Kaplan, M … - Cancer treatment …, 1979 - ncbi.nlm.nih.gov Combination chemotherapy consisting of hexamethylmelamine, adriamycin, and
cis-dichlorodiammineplatinum(II) was given to 27 patients with advanced epithelial ovarian cancer
whose disease had progressed while receiving therapy including alkylating agents. ... Cited by 63 - Related articles
CJ Williams, M DM, DM Ben Mead, A Arnold, … - CA A Cancer Journal … - interscience.wiley.com Thirty five-previously untreated patients with FIGO Stage III or IV ovarian carcinoma were treated
with cis-diamminedichloroplatinum (II), Adriamycin and cyclophosphamide (PACe). Following
four or five cycles of PACe, patients were assessed clinically for response. Twenty-one ... Cited by 37 - Related articles - All 2 versions
[CITATION] Cytoreductive surgical treatment in the management of advanced ovarian cancer
- ►ajronline.org [PDF] NR Dunnick, RB Jones, JL Doppman, J … - AJR. American journal …, 1979 - ncbi.nlm.nih.gov For patients undergoing intraperitoneal ("belly bath") chemotherapy, it is useful to verify the distribution
of infusion fluid. For this reason, 10 patients were examined by computed tomography (CT) after
intraperitoneal instillation of dialysate mixed with water soluble contrast material. The ... Cited by 80 - Related articles - All 2 versions
[CITATION] Radiation therapy of ovarian carcinoma
AJ Dembo, RS Bush - Gynecologic oncology: cancer treatment and research. …, 1983 Cited by 10 - Related articles
TG Day Jr, JP Smith - Seminars in oncology, 1975 - ncbi.nlm.nih.gov The early diagnosis of ovarian carcinoma will await the development of adequate and accurate
screening tests. In the interval prior to development of these tests, ovarian cancers will frequently
be discovered in an advanced stage. Improved methods of treatment must be based on ... Cited by 33 - Related articles
